4-BROMOPYRAZOLO[1,5-A]PYRIDIN-2-AMINE, 95.0%, 500mg

Ethyl 4-oxo-4H-pyran-2-carboxylate, 95.0%, 100mg

2,3-dihydroxybenzaldehyde, min. 98%, 1 g, glass packaging

Maleic Acid Monoamide>98.0%(HPLC)(T)500g

2-((2S,5S)-5-methyl-3,6-dioxopiperazin-2-yl)acetic acid, 95.0%, 250mg

1,2-benzisothiazole-3-acetic acid, 97%, 1g

5-Amino-1-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 98%, 10g

Lithium citrate (tetrahydrate), 100mg

4-Fluoroindole, 98.0%, 500g

(2S,3S)-4-(Anthracen-9-yl)-3-(tert-butyl)-2-ethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 250mg

2,6-Dimethoxyphenol>98.0%(GC)100g

(2-(Thiomorpholinomethyl)phenyl)boronic acid, 98%, 250mg

1-tert-Butyl 2-methyl (2R,4R)-4-hydroxypiperidine-1,2-dicarboxylate, 98%, 250mg